Q2 2023 · 13F-HR
Ikarian Capital, LLCholdings as filed
Filed 2023-08-14 · accession 0001420506-23-001546
$627.9M
Reported value
122
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00445A100 | — | ACELYRIN INC | $61.0M | 9.71% | 2,918,426 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $51.5M | 8.20% | 132,100 | PUT | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $21.2M | 3.37% | 1,229,800 | CALL | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $20.6M | 3.27% | 936,800 | CALL | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $20.5M | 3.27% | 826,100 | PUT | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $20.5M | 3.27% | 826,100 | CALL | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $17.9M | 2.85% | 250,000 | CALL | SOLE |
| 04016X101 | ARGX | ARGENX SE | $14.8M | 2.36% | 38,000 | CALL | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $14.0M | 2.23% | 122,100 | PUT | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $12.3M | 1.95% | 374,100 | PUT | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $12.2M | 1.94% | 133,800 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $12.1M | 1.93% | 133,000 | PUT | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $11.5M | 1.84% | 100,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $11.5M | 1.84% | 490,893 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $11.5M | 1.83% | 272,752 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $11.2M | 1.79% | 200,000 | CALL | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $11.2M | 1.79% | 200,000 | PUT | SOLE |
| 75615P103 | — | REATA PHARMACEUTICALS INC | $11.2M | 1.79% | 110,000 | CALL | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $10.7M | 1.70% | 240,031 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $10.2M | 1.63% | 485,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $10.2M | 1.63% | 427,417 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $8.7M | 1.38% | 100,000 | PUT | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $8.6M | 1.36% | 475,000 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $8.4M | 1.35% | 447,700 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $8.3M | 1.32% | 796,300 | PUT | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $8.1M | 1.29% | 348,200 | PUT | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $7.4M | 1.18% | 429,686 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $7.0M | 1.11% | 140,000 | Common | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $6.6M | 1.06% | 611,932 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $6.6M | 1.05% | 350,000 | CALL | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $6.3M | 1.00% | 286,700 | PUT | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $6.2M | 0.99% | 326,200 | CALL | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $6.1M | 0.96% | 275,875 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $5.8M | 0.93% | 211,400 | PUT | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $5.7M | 0.91% | 280,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $5.6M | 0.89% | 121,658 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $5.5M | 0.88% | 200,000 | CALL | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $5.4M | 0.86% | 225,000 | CALL | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $5.3M | 0.84% | 228,300 | CALL | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $5.2M | 0.83% | 135,486 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $5.2M | 0.83% | 203,037 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $4.8M | 0.77% | 579,390 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $4.7M | 0.76% | 68,800 | CALL | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $4.6M | 0.74% | 130,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $4.2M | 0.67% | 200,000 | CALL | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $4.1M | 0.65% | 200,000 | CALL | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $4.0M | 0.64% | 978,626 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $3.7M | 0.59% | 504,253 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $3.4M | 0.55% | 300,000 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $3.4M | 0.54% | 772,092 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $3.2M | 0.50% | 654,945 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $3.0M | 0.47% | 400,000 | CALL | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $3.0M | 0.47% | 400,000 | PUT | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $2.8M | 0.44% | 315,480 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $2.8M | 0.44% | 545,103 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $2.6M | 0.41% | 150,000 | PUT | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $2.5M | 0.40% | 22,100 | CALL | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $2.5M | 0.39% | 174,510 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $2.4M | 0.38% | 1,705,605 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $2.3M | 0.36% | 215,200 | CALL | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $2.3M | 0.36% | 225,000 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $2.1M | 0.33% | 100,000 | CALL | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $2.1M | 0.33% | 200,163 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $2.1M | 0.33% | 841,596 | Common | SOLE |
| 23345J104 | — | DICE THERAPEUTICS INC | $2.0M | 0.32% | 43,600 | PUT | SOLE |
| 09074F207 | — | BIOVIE INC | $1.9M | 0.31% | 448,556 | Common | SOLE |
| 45845P108 | — | INTERCEPT PHARMACEUTICALS IN | $1.8M | 0.28% | 160,200 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.8M | 0.28% | 154,400 | CALL | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.8M | 0.28% | 200,000 | CALL | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $1.7M | 0.28% | 1,149,490 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $1.7M | 0.27% | 25,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $1.7M | 0.26% | 63,125 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $1.6M | 0.26% | 650,000 | Common | SOLE |
| 471871103 | — | JASPER THERAPEUTICS INC | $1.5M | 0.25% | 1,125,087 | Common | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $1.5M | 0.24% | 150,000 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $1.5M | 0.24% | 192,260 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $1.4M | 0.23% | 76,000 | PUT | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $1.4M | 0.22% | 412,628 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $1.3M | 0.21% | 460,416 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $1.3M | 0.20% | 140,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $1.2M | 0.19% | 10,300 | PUT | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $1.1M | 0.17% | 400,000 | CALL | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $1.0M | 0.16% | 379,300 | PUT | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $1.0M | 0.16% | 155,819 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $966,700 | 0.15% | 35,000 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $945,216 | 0.15% | 278,825 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $820,336 | 0.13% | 48,170 | Common | SOLE |
| 89237H209 | — | TRACON PHARMACEUTICALS INC | $804,769 | 0.13% | 2,765,530 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $765,653 | 0.12% | 472,625 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $748,245 | 0.12% | 70,390 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $743,150 | 0.12% | 62,766 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $716,000 | 0.11% | 400,000 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $677,318 | 0.11% | 349,133 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $619,006 | 0.10% | 260,087 | Common | SOLE |
| 31572Q808 | FGENEUR | FIBROGEN INC | $616,735 | 0.10% | 228,420 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $565,817 | 0.09% | 49,031 | Common | SOLE |
| 75615P103 | — | REATA PHARMACEUTICALS INC | $557,925 | 0.09% | 5,472 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA INC | $528,000 | 0.08% | 600,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $516,000 | 0.08% | 100,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $450,907 | 0.07% | 188,664 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $431,436 | 0.07% | 62,527 | Common | SOLE |
| 10501E201 | BCLIEUR | BRAINSTORM CELL THERAPEUTICS | $391,266 | 0.06% | 189,935 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $363,874 | 0.06% | 110,600 | CALL | SOLE |
| 034569103 | ANEB | ANEBULO PHARMACEUTICALS INC | $340,523 | 0.05% | 156,203 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $303,908 | 0.05% | 221,830 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $300,235 | 0.05% | 891,676 | Common | SOLE |
| 16385C104 | — | CHEMOMAB THERAPEUTICS LTD | $279,543 | 0.04% | 213,392 | Common | SOLE |
| 730541109 | — | POINT BIOPHARMA GLOBAL INC | $260,783 | 0.04% | 28,784 | Common | SOLE |
| 207523101 | — | CONNECT BIOPHARMA HLDGS LTD | $243,645 | 0.04% | 219,501 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $219,207 | 0.03% | 313,677 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $186,532 | 0.03% | 2,090 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $185,548 | 0.03% | 4,400 | CALL | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $164,501 | 0.03% | 50,000 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $161,109 | 0.03% | 65,491 | Common | SOLE |
| 87166L100 | — | SYNLOGIC INC | $131,905 | 0.02% | 306,757 | Common | SOLE |
| 16961L106 | — | CHINOOK THERAPEUTICS INC | $130,394 | 0.02% | 283,464 | Common | SOLE |
| 05455M100 | — | AVROBIO INC | $127,453 | 0.02% | 134,146 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $105,601 | 0.02% | 15,000 | Common | SOLE |
| 31773D200 | FNCHQ | FINCH THERAPEUTICS GROUP INC | $67,533 | 0.01% | 7,917 | Common | SOLE |
| 04522R200 | — | ASLAN PHARMACEUTICALS LTD | $29,813 | 0.00% | 164,088 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $17,325 | 0.00% | 75 | Common | SOLE |
| 29604W108 | — | PHAXIAM THERAPEUTICS S A | $2,257 | 0.00% | 3,019 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.